These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22569123)

  • 1. TARGIT-E(lderly)--prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.
    Neumaier C; Elena S; Grit W; Yasser AM; Uta KT; Anke K; Axel G; Marc S; Frederik W
    BMC Cancer; 2012 May; 12():171. PubMed ID: 22569123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
    Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
    Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
    Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
    Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
    Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
    Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.
    Mellon EA; Orman A; Joya LE; Montejo ME; Laronga C; Hoover SJ; Lee MC; Khakpour N; Kubal PF; Diaz R
    Brachytherapy; 2017; 16(1):174-180. PubMed ID: 27816540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.
    Elsberger B; Romsauerova A; Vinnicombe S; Whelehan P; Brown DC; Dewar JA; Thompson AM; Evans A
    Eur J Surg Oncol; 2014 Feb; 40(2):163-7. PubMed ID: 24332581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
    Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
    JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
    Ahn SG; Bae SJ; Lee HW; Yoon CI; Kim JW; Lee IJ; Jeong J
    Breast Cancer Res Treat; 2019 Feb; 174(1):157-163. PubMed ID: 30467660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
    Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
    Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
    Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
    Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer.
    Abo-Madyan Y; Welzel G; Sperk E; Neumaier C; Keller A; Clausen S; Schneider F; Ehmann M; Sütterlin M; Wenz F
    Strahlenther Onkol; 2019 Jul; 195(7):640-647. PubMed ID: 30796496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative Radiotherapy for Breast Cancer in Elderly Women.
    Guillerm SO; Bourstyn E; Itti R; Cahen-Doidy L; Quéro L; Labidi M; Marchand E; Lorphelin H; Giacchetti S; Cuvier C; Espié M; Teixeira L; Hennequin C
    Clin Breast Cancer; 2022 Jan; 22(1):e109-e113. PubMed ID: 34154928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
    Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
    Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.